TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Amy Rabideau, Ph.D.
Senior Scientist, Drug Substance Process Development at Moderna

Profile

Dr. Amy Rabideau is a Senior Scientist in the Drug Substance Process Development team at Moderna in Cambridge, MA, a biotechnology company focused on producing messenger RNA medicines. As a research scientist and team leader at Moderna, Amy works to identify and refine strategies used to produce highly pure mRNA for vaccine and therapeutic development. Prior to working at Moderna, Amy received her Ph.D. in Biological Chemistry from MIT, under the mentorship of Associate Professor Brad Pentelute. She completed her B.S. in Chemistry and Biology with honors from Syracuse University.

Amy Rabideau, Ph.D.'s Network

Agenda Sessions

  • Immune Modulation of mRNA

    , 15:30

Speakers at this event